/ /

  • linkedin
  • Increase Font
  • Sharebar

    Cannabis remains problematic for glaucoma


    In any event, glaucoma patients are not rushing to treat themselves with cannabis, according to a July 2016 survey of patients in Colorado and Oregon; fewer than 2% of medical users listed glaucoma as a reason.

    Even if cannabinoids are not useful in treating glaucoma themselves, their potent effect on IOP might yield insights leading to better treatments.

    But at the moment, research is difficult because federal law has limited the source of cannabis for research to a single site at the University of Mississippi.

    This cannabis has lower potency than cannabis sold in state regulated markets, and doesn’t reflect the variety of products on the street.

    In August 2016, the DEA announced plans to expand the number of registered marijuana manufacturers, but it’s too early to say how this will effect research in glaucoma, Dr. Radhakrishnan said.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results